Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C9H6O3 |
| Molecular Weight | 162.1421 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=CC(=O)OC2=C1C=CC=C2
InChI
InChIKey=VXIXUWQIVKSKSA-UHFFFAOYSA-N
InChI=1S/C9H6O3/c10-7-5-9(11)12-8-4-2-1-3-6(7)8/h1-5,10H
| Molecular Formula | C9H6O3 |
| Molecular Weight | 162.1421 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Synthesis and biological evaluation of coumarin derivatives as inhibitors of Mycobacterium bovis (BCG). | 2012-12 |
|
| 3-Acetyl-4-hy-droxy-6,7-dimethyl-2H-chromen-2-one. | 2010-11-13 |
|
| Molecular Basis for Drug Resistance in HIV-1 Protease. | 2010-11 |
|
| Synthesis of functionalized chromenes from Meldrum's acid, 4-hydroxycoumarin, and ketones or aldehydes. | 2010-11 |
|
| Warfarin: an environment-dependent switchable molecular probe. | 2010-10-30 |
|
| Regulators of the proteasome pathway, Uch37 and Rpn13, play distinct roles in mouse development. | 2010-10-27 |
|
| Structure-activity relationships of new 4-hydroxy bis-coumarins as radical scavengers and chain-breaking antioxidants. | 2010-09 |
|
| 2,2,4-Trimethyl-7-nitro-2,3-dihydro-1H-1,5-benzodiazepin-5-ium perchlorate. | 2010-06-26 |
|
| Genetic variations in human glutathione transferase enzymes: significance for pharmacology and toxicology. | 2010-06-13 |
|
| Design of novel 4-hydroxy-chromene-2-one derivatives as antimicrobial agents. | 2010-06-11 |
|
| Synthesis, anticoagulant and PIVKA-II induced by new 4-hydroxycoumarin derivatives. | 2010-05-15 |
|
| Inhibition of human DHODH by 4-hydroxycoumarins, fenamic acids, and N-(alkylcarbonyl)anthranilic acids identified by structure-guided fragment selection. | 2010-04-06 |
|
| Antimetastatic, antineoplastic, and toxic effects of 4-hydroxycoumarin in a preclinical mouse melanoma model. | 2010-04 |
|
| Ultrasound-assisted one-pot, three-component synthesis of spiro[indoline-3,4'-pyrazolo[3,4-b]pyridine]-2,6'(1'H)-diones in water. | 2010-02 |
|
| A novel 4-hydroxycoumarin biosynthetic pathway. | 2010-01 |
|
| Synthesis of 3-amino-4-hydroxy coumarin and dihydroxy-phenyl coumarins as novel anticoagulants. | 2010 |
|
| (4R)-Ethyl 4-(4-chloro-phen-yl)-2-hydr-oxy-5-oxo-2,3,4,5-tetra-hydro-pyrano[3,2-c]chromene-2-carboxyl-ate. | 2009-12-19 |
|
| Synthesis and insecticidal activity of new 4-hydroxy-2H-1-benzopyran-2-one derivatives. | 2009-12 |
|
| Synthesis and biological evaluation of coumarin-based inhibitors of NAD(P)H: quinone oxidoreductase-1 (NQO1). | 2009-11-26 |
|
| 4,4-Dimethyl-2-tosyl-1,2,3,3a,4,11b-hexa-hydro-11H-pyrrolo[3,4-c]pyrano[5,6-c]chromen-11-one 0.125-hydrate. | 2009-10-31 |
|
| Diastereoselective synthesis of trans-2,3-dihydrofurans with pyridinium ylide assisted tandem reaction. | 2009-10-02 |
|
| Formation of coumarines during the degradation of alkyl substituted aromatic oil components by the yeast Trichosporon asahii. | 2009-10 |
|
| HPLC method for simultaneous determination of impurities and degradation products in zonisamide. | 2009-09 |
|
| Study on the inhibitory mechanism and binding mode of the hydroxycoumarin compound NSC158393 to HIV-1 integrase by molecular modeling. | 2009-09 |
|
| Ethyl 2-hydr-oxy-5-oxo-4-phenyl-2,3,4,5-tetra-hydro-pyrano[3,2-c]chromene-2-carboxyl-ate. | 2009-07-25 |
|
| Investigation of the antioxidant properties of some new 4-hydroxycoumarin derivatives. | 2009-07 |
|
| 4-Hydr-oxy-3-[(2E)-3-(3,4,5-trimethoxy-phen-yl)prop-2-eno-yl]-2H-chromen-2-one. | 2009-06-20 |
|
| Synthesis and studies of new 2-(coumarin-4-yloxy)-4,6-(substituted)-S-triazine derivatives as potential anti-HIV agents. | 2009-05 |
|
| Reactions of 3-benzoyl-7-dimethylamino-4-hydroxycoumarin and their potential applications in solution- and solid-phase synthesis. | 2009-05 |
|
| Evaluation of alternatives to warfarin as probes for Sudlow site I of human serum albumin: characterization by high-performance affinity chromatography. | 2009-04-17 |
|
| Synthesis and molecular descriptor characterization of novel 4-hydroxy-chromene-2-one derivatives as antimicrobial agents. | 2009-04-14 |
|
| Redox active donor-substituted punicin derivatives. | 2009-04-07 |
|
| 3-Anilinothio-carbonyl-4-hydroxy-chromen-2-one. | 2009-03-31 |
|
| Design and microwave-assisted synthesis of naphtho[2,3-f]quinoline derivatives and their luminescent properties. | 2009-03-09 |
|
| Biosynthesis of biphenyls and benzophenones--evolution of benzoic acid-specific type III polyketide synthases in plants. | 2009-03-02 |
|
| Systems pharmacology and genome medicine: a future perspective. | 2009-01-22 |
|
| Pharmacogenomics of anticoagulants: steps toward personal dosage. | 2009-01-21 |
|
| Electrochemical synthesis of 4-(dihydroxyphenylthio)-2H-chromen-2-one derivatives. | 2008-11 |
|
| Coumarin, anthroquinone and stilbene derivatives with anticholinesterase activity. | 2008-08-02 |
|
| The synthesis and antimicrobial activity of some 4-hydroxycoumarin derivatives. | 2008-08 |
|
| Synthesis and antimicrobial evaluation of some novel 2-aminothiazole derivatives of 4-hydroxy-chromene-2-one. | 2008-08 |
|
| 2-Amino-4'-bromo-2',5-dioxo-4H,5H-pyrano[3,2-c]chromene-4-spiro-3'(2'H)-1'H-indole-3-carbonitrile N,N-dimethyl-formamide solvate. | 2008-05-30 |
|
| 3D-QSAR investigation of synthetic antioxidant chromone derivatives by molecular field analysis. | 2008-03 |
|
| Comparison of the effect of 4-hydroxycoumarin and umbelliferone on the phase transition of dipalmitoylphosphatidylcholine (DPPC) bilayers. | 2007-06-22 |
|
| Antifungal and antibacterial activities of Mexican tarragon (Tagetes lucida). | 2006-05-17 |
|
| Biotin-avidin amplified enzyme-linked immunosorbent assay for determination of isoflavone daidzein. | 2005-02-15 |
|
| Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications. | 1997-12 |
|
| Coumarin-based inhibitors of HIV integrase. | 1997-01-17 |
|
| Competitive inhibition of HIV-1 protease by 4-hydroxy-benzopyran-2-ones and by 4-hydroxy-6-phenylpyran-2-ones. | 1994-05-16 |
|
| Inhibitory effect of coumarins on HIV-1 replication and cell-mediated or cell-free viral transmission. | 1993-08 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:39:02 GMT 2025
by
admin
on
Mon Mar 31 19:39:02 GMT 2025
|
| Record UNII |
X954ZLL2RD
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
214-060-2
Created by
admin on Mon Mar 31 19:39:02 GMT 2025 , Edited by admin on Mon Mar 31 19:39:02 GMT 2025
|
PRIMARY | |||
|
54682930
Created by
admin on Mon Mar 31 19:39:02 GMT 2025 , Edited by admin on Mon Mar 31 19:39:02 GMT 2025
|
PRIMARY | |||
|
11889
Created by
admin on Mon Mar 31 19:39:02 GMT 2025 , Edited by admin on Mon Mar 31 19:39:02 GMT 2025
|
PRIMARY | |||
|
4-Hydroxycoumarin
Created by
admin on Mon Mar 31 19:39:02 GMT 2025 , Edited by admin on Mon Mar 31 19:39:02 GMT 2025
|
PRIMARY | |||
|
40070
Created by
admin on Mon Mar 31 19:39:02 GMT 2025 , Edited by admin on Mon Mar 31 19:39:02 GMT 2025
|
PRIMARY | |||
|
77858
Created by
admin on Mon Mar 31 19:39:02 GMT 2025 , Edited by admin on Mon Mar 31 19:39:02 GMT 2025
|
PRIMARY | |||
|
X954ZLL2RD
Created by
admin on Mon Mar 31 19:39:02 GMT 2025 , Edited by admin on Mon Mar 31 19:39:02 GMT 2025
|
PRIMARY | |||
|
DTXSID8061472
Created by
admin on Mon Mar 31 19:39:02 GMT 2025 , Edited by admin on Mon Mar 31 19:39:02 GMT 2025
|
PRIMARY | |||
|
1076-38-6
Created by
admin on Mon Mar 31 19:39:02 GMT 2025 , Edited by admin on Mon Mar 31 19:39:02 GMT 2025
|
PRIMARY | |||
|
DB03410
Created by
admin on Mon Mar 31 19:39:02 GMT 2025 , Edited by admin on Mon Mar 31 19:39:02 GMT 2025
|
PRIMARY | |||
|
C068805
Created by
admin on Mon Mar 31 19:39:02 GMT 2025 , Edited by admin on Mon Mar 31 19:39:02 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
PARENT -> IMPURITY |
correction factors: for the calculation of content, multiply the peak areas of the following impurity by the corresponding correction factor: impurity B = 0.5
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|